Imidazoleacetic Acid

Imidazoleacetic Acid

SCHEMBL2172193

Cl.O=C(O)Cc1ncc[nH]1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Imidazoleacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 4/20 0.49
GLA known ✓ P06280 1/20 0.40
HTR1A known ✓ P08908 1/20 0.40
TBXAS1 P24557 2/20 0.59
SMN1; SMN2 Q16637 3/20 0.49
TAAR1 Q96RJ0 4/20 0.46
KDM4E B2RXH2 3/20 0.44
HTT P42858 3/20 0.44
FDPS P14324 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALOX15 P16050 1/20 0.42
PMP22 Q01453 2/20 0.41
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GABRR1 P24046 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidazoleacetic Acid SCHEMBL360337 0.98
Imidazoleacetic Acid SCHEMBL15007471 0.96 TBXAS1 (0.56) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL17375738 0.96 TBXAS1 (0.56) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL2827600 0.94 TBXAS1 (0.54) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL26627272 0.90 TBXAS1 (0.51) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL28462628 0.90 TBXAS1 (0.51) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL8706716 0.86 TBXAS1 (0.47) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Imidazoleacetic Acid SCHEMBL16339368 0.84 TBXAS1 (0.46) TBXAS1GAASMN1; SMN2TAAR1KDM4E
Hydrochloric Acid SCHEMBL3184145 0.84 TBXAS1 (0.51) TBXAS1GAASMN1; SMN2TAAR1KDM4E
SCHEMBL8519473 0.83 TBXAS1 (0.50) TBXAS1GAASMN1; SMN2TAAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112058103-B Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2022-06-21 CN claimed
CN-112058103-A Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2020-12-11 CN claimed
WO-2005063717-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF ZOLEDRONIC ACID NATCO PHARMA LIMITED (IN) 2005-07-14 WO claimed
WO-2023145880-A1 GLUTAMINASE INHIBITOR 国立大学法人富山大学 2023-08-03 WO disclosed
CN-112058103-B Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2022-06-21 CN disclosed
CN-112058103-B Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2022-06-21 CN disclosed
CN-112058103-B Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2022-06-21 CN disclosed
CN-112058103-A Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2020-12-11 CN disclosed
CN-112058103-A Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2020-12-11 CN disclosed
CN-112058103-A Cellulose grafted carboxymethyl imidazole chloride salt gas separation membrane and preparation method thereof 齐齐哈尔大学 2020-12-11 CN disclosed
CN-102775444-A New preparation method of zoledronic acid HENGSHUI KANGYI MEDICAL TECHNOLOGY DEV CO LTD 2012-11-14 CN disclosed
WO-2005005447-A2 ZOLEDRONIC ACID CRYSTAL FORMS, ZOLEDRONATE SODIUM SALT CRYSTAL FORMS, AMORPHOUS ZOLEDRONATE SODIUM SALT, AND PROCESSES FOR THEIR PREPARATION TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2005-01-20 WO disclosed
EP-1020179-A2 PEPTIDE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCING THE SAME, USE OF SAID DERIVATIVES AND PHARMACEUTICAL COMPOSITION Nebolsin, Vladimir Evgenievich (RU) 2000-07-19 EP disclosed
US-5872135-A ENZYME INHIBITORS MERK & CO., INC. (US) 1999-02-16 US disclosed
US-5661161-A Inhibitors of farnesyl-protein transferase MERCK & CO., INC. (US) 1997-08-26 US disclosed
EP-0783518-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1997-07-16 EP disclosed
WO-1996010035-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1996-04-04 WO disclosed
EP-0663834-A4 GROWTH HORMONE RELEASING PEPTIDES. SMITHKLINE BEECHAM CORP (US) 1996-01-24 EP disclosed
EP-0663834-A1 GROWTH HORMONE RELEASING PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1995-07-26 EP disclosed
WO-1994007519-A1 GROWTH HORMONE RELEASING PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-04-14 WO disclosed